Fujian, China

Jian MA

This inventor holds 1 USPTO granted patent. Top assignees: Xiamen University, Yang Sheng Tang Company Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jian MA. Retrieved from https://idiyas.com/inventor/jian-ma-g5ij9hgk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jian Ma

Introduction

Jian Ma is a notable inventor based in Fujian, China. He has made significant contributions to the field of antiviral treatments, particularly in the fight against hepatitis B. His work has implications for improving health outcomes for patients affected by this virus.

Latest Patents

Jian Ma holds a patent for the use of palovarotene in the treatment against the HBV virus. This patent relates specifically to the antiviral treatment of hepatitis B and involves the use of a compound represented by a specific formula in combating the HBV virus. His innovative approach highlights the potential for new therapeutic options in this area.

Career Highlights

Throughout his career, Jian Ma has worked with reputable organizations, including Yang Sheng Tang Company Limited and Xiamen University. His experience in these institutions has allowed him to develop and refine his research in antiviral treatments, contributing to the advancement of medical science.

Collaborations

Jian Ma has collaborated with various professionals in his field, including his coworker Jiali Cao. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.

Conclusion

Jian Ma's contributions to antiviral treatment research, particularly against hepatitis B, underscore his role as an innovative inventor. His patent and collaborations reflect a commitment to advancing medical science and improving patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…